Journey Medical Corporation (DERM)

NASDAQ: DERM · Real-Time Price · USD

7.86

-0.04 (-0.51%)

Sep 4, 2026, 4:00 PM EDT - Market closed

Journey Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	222	209	82	107	34	90
Market Cap Growth	21.32%	156.14%	-23.38%	212.54%	-61.94%	-
Enterprise Value	222	210	80	85	25	109
Last Close Price	7.86	7.71	3.91	5.76	1.92	5.38

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	39.80	61.68	-	-	-	-
PS Ratio	3.25	3.38	1.46	1.35	0.46	1.42
PB Ratio	6.77	6.57	4.07	5.24	2.01	2.13
P/TBV Ratio	33.59	49.26	-	1692.20	-	3.04
P/FCF Ratio	-	-	-	20.35	-	-
P/OCF Ratio	-	-	-	20.35	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.25	3.39	1.43	1.07	0.33	1.73
EV/EBITDA Ratio	182.35	-	-	17.57	-	-
EV/EBIT Ratio	-	-	-	79.43	-	-
EV/FCF Ratio	-	-	-	16.22	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.80	0.80	1.28	0.87	1.57	0.22
Debt / EBITDA Ratio	19.32	-	-	3.59	-	-
Debt / FCF Ratio	-	-	-	3.38	-	-
Net Debt / Equity Ratio	0.00	0.04	0.27	-0.48	-0.32	-0.95
Net Debt / EBITDA Ratio	-0.08	-0.33	-0.53	-2.01	0.23	2.45
Net Debt / FCF Ratio	0.01	-0.10	-0.59	-1.85	0.40	18.36
Asset Turnover	0.76	0.71	0.72	0.87	0.73	0.85
Inventory Turnover	2.24	1.74	1.70	1.88	2.56	4.54
Quick Ratio	1.35	1.44	0.87	1.02	0.90	1.40
Current Ratio	1.59	1.79	1.37	1.35	1.16	1.64
Return on Equity (ROE)	-23.77%	-44.03%	-72.60%	-20.64%	-100.39%	-168.12%
Return on Assets (ROA)	-2.09%	-5.84%	-10.88%	0.73%	-16.99%	-15.79%
Return on Invested Capital (ROIC)	-9.85%	-27.88%	-75.75%	9.62%	-404.39%	-170.38%
Return on Capital Employed (ROCE)	-5.70%	-14.30%	-30.30%	3.10%	-71.80%	-41.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-2.75%	-5.46%	-17.96%	-3.61%	-86.86%	-49.09%
FCF Yield	-3.38%	-5.95%	-11.17%	4.92%	-39.68%	-2.43%
Buyback Yield / Dilution	-21.63%	-19.90%	-12.06%	-4.00%	-72.05%	5.96%

SEC Filings: 10-K · 10-Q